New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
08:22 EDTRTRX, TXMDRetrophin CEO in scandal over Twitter use, TheStreet reports
Retrophin has placed the company's social media activity on "lockdown" following questionable tweets from CEO Martin Shkreli, including one that seemed to hint at a Retrophin acquisition of an approved drug from a private company, reported TheStreet's Adam Feuerstein. The social media blackout also follows the discovery that employees were using Twitter aliases to promote Retrophin and pitch short-sale recommendations of other stocks, including a tweet that singled out TherapeuticsMD (TXMD), the report added. Reference Link
News For RTRX;TXMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
18:36 EDTRTRXOn The Fly: After Hours Movers
Subscribe for More Information
17:04 EDTTXMDTherapeuticsMD granted two new patents
Subscribe for More Information
17:02 EDTRTRXRetrophin appoints Stephen Aselage as interim CEO
Subscribe for More Information
September 29, 2014
16:07 EDTTXMDTherapeuticsMD begins phase 3 clinical trial of TX-004HR
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use